Announcement
29 Jan 2021
In January 2021, the European Union announced the establishment of a transparency and export authorisation scheme for COVID-19 vaccines.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
30 Jan 2021
Revocation date:
25 Mar 2021
Updated: 29 Jan 2021
Export licensing requirement
On 30 January 2021, the EU adopted Commission Implementing Regulation (EU) 2021/111 that establishes a temporary export authorisation mechanism for the export of COVID-19 vaccines from c...
Sign in to see more
Related State Acts
25 Mar 2021
EU: Commission amends the export authorisation scheme for COVID-19 vaccines
12 Mar 2021
EU: Commission adds new products to the temporary export authorisation scheme for COVID-19 vaccines and active substances
11 Dec 2020
EU: Temporary VAT relief to COVID-19 vaccines and testing kits
30 Nov 2020
EU: COVID-19 Advanced Purchase Agreement with CureVac includes localisation requirement
20 Nov 2020
EU: Localisation requirement included in the Advanced Purchase Agreement with BioNTech-Pfizer
18 Sep 2020
EU: Advanced Purchase Agreement with Sanofi-GSK includes localisation incentive
27 Aug 2020
EU: COVID-19 Advanced Purchase Agreement with AstraZeneca includes localisation requirement
27 Jun 2020
Germany: EIB and European Commission provide financing for vaccine development and expansion of manufacturing
Threads
See all
This state act is not part of any Thread yet.